Cutaneous side-effects of transdermal iontophoresis with and without surfactant pretreatment: A single-blinded, randomized controlled trial

British Journal of Dermatology

Volumn 153, Issue 2, 2005, Pages 404-412

  Li, G L ^a   Van Steeg, T J ^a   Putter, H ^b   Van Der Spek, J ^a   Pavel, S ^b   Danhof, M ^a   Bouwstra, Joke A ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cutaneous side effect; Human volunteer; Iontophoresis; Surfactant formulation pretreatment

Indexed keywords

SURFACTANT;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG FORMULATION; ERYTHEMA; FEMALE; HUMAN; IONTOPHORESIS; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN COLOR; SKIN IRRITATION; SKIN TINGLING; SKIN WATER LOSS;

ADULT; COMBINED MODALITY THERAPY; EDEMA; ERYTHEMA; FEMALE; HUMANS; IONTOPHORESIS; MALE; MIDDLE AGED; SINGLE-BLIND METHOD; SKIN DISEASES; SKIN TEMPERATURE; SURFACE-ACTIVE AGENTS; WATER LOSS, INSENSIBLE;

EID: 24144455354     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2005.06741.x     Document Type: Article

References (29)

1. Nair V, Pillai O, Poduri R, Panchagnula R. Transdermal iontophoresis. Part I. Basic principles and considerations. Meth Find Exp Clin Pharmacol 1999; 21:139-51.
2. Guy RH, Kalia YN, Delgado-Charro MB et al. Iontophoresis: electroreplusion and electroosmosis. J Control Rel 2000; 64:129-32.
3. Singh P, Roberts MS. Iontophoretic transdermal delivery of salicylic acid and lidocaine to local subcutaneous structures. J Pharm Sci 1993; 82:127-31.
4. Ashburn MA, Streisan J, Zhong J et al. The iontophoresis fentanyl citrate in humans. Anesthesiology 1995; 82:1146-53.
5. Delgado-Charro MB, Guy RH. Iontophoresis of peptides. In: Electronically Controlled Drug Delivery (Berner B, Dinh SM, eds). Boca Raton: CRC Press LLC, 1998: 129-57.
6. Ledger PW. Skin biological issues in electrically enhanced transdermal delivery. Adv Drug Deliv Rev 1992; 9:289-307.
7. Camel E, O'Connel M, Sage B et al. The effect of saline iontophoresis on skin integrity in human volunteers. I. Methodology and reproducibility. Fundam Appl Toxicol 1996; 32:168-78.
8. Singh J, Gross M, Sage B et al. Effect of saline iontophoresis on skin barrier function and cutaneous irritation in four ethnic groups. Food Chem Toxicol 2000; 38:717-26.
9. Singh J, Gross M, Sage B et al. Regional variations in skin barrier function and cutaneous irritation due to iontophoresis in human subjects. Food Chem Toxicol 2001; 39:1079-86.
10. Li GL, Danhof M, Frederik PM, Bouwstra JA. Pretreatment with a water-based surfactant formulation affects transdermal iontophoretic delivery of R-apomorphine in vitro. Pharm Res 2003; 20:653-9.
11. van der Geest R, Laar T, Gubbens-Stibbe J et al. Iontophoretic delivery of apomorphine. II. An in vivo study in patients with Parkinson's disease. Pharm Res 1997; 14:1804-10.
12. Draize J, Woodard G, Calvery H. Methods for the study of irritation and toxicity of substances applied to the skin and mucous membranes. J Pharmacol Exp Ther 1944; 82:377-90.
13. Cosmetic Ingredient Review Expert Panel. Final report on the safety assessment of sodium laureth sulfate and ammonium laureth sulfate. J Am Coll Toxicol 1983; 2:1-34.
14. Pinnagoda J, Tupker RA, Agner T, Serup J. Guidelines for transdermal water loss (TEWL) measurement. A report from the Standardization Group of the European Society of Contact Dermatitis. Contact Dermatitis 1990; 22:164-78.
15. Wilhelm KP, Surber C, Maibach HI. Quantification of sodium lauryl sulphate irritant dermatitis in man: comparison of four techniques: skin color reflectance, trandermal water loss, laser Doppler flow measurement and visual scores. Arch Dermatol Res 1989; 281:1-3.
16. Pinheiro JC, Bates DM. Mixed-Effects Models in S and S-Plus. New York: Springer-Verlag, 2000.
17. Laird NM, Ware JH. Random-effects models for longitudinal data. Biometrics 1982; 38:963-74.
18. Ashburn MA, Gauthier M, Love G et al. Iontophoretic administration of 2% lidocaine HCl and 1: 100 000 epinephrine in humans. Clin J Pain 1997; 13:22-6.
19. Brand RM, Singh P, Aspe-Carranza E et al. Acute effects of iontophoresis on human skin in vivo: cutaneous blood flow and transepidermal water loss measurements. Eur J Pharm Biopharm 1997; 43:133-8.
20. Thysman S, Neste D, Préat V. Noninvasive investigation of human skin after in vivo iontophoresis. Skin Pharmacol 1995; 8:229-36.
21. Idson DR. In vivo measurement of transepidermal water loss. J Soc Cosmet Chem 1978; 29:573-80.
22. van der Valk PG, Nater JP, Bleumink E. Skin irritancy of surfactants as assessed by water vapor loss measurements. J Invest Dermatol 1984; 82:291-3.
23. Curdy C, Naik A, Kalia YN et al. Non-invasive assessment of the effect of formulation excipients on stratum corneum barrier function in vivo. Int J Pharm 2004; 271:251-6.
24. Curdy C, Kalia YN, Guy RH. Non-invasive assessment of the effects of iontophoresis on human skin in vivo. J Pharm Pharmacol 2001; 53:769-77.
25. Prottey C. The molecular basis of skin irritation. In: Cosmetic Science I (Breuer MM, ed.). London: Academic Press, 1978: 275-349.
26. Rietschel RL. Mechanisms in irritant contact dermatitis. Clin Dermatol 1997; 15:557-9.
27. Instruction guides to the Phoresor II Iontophoresis Drug Delivery System and Ioflex EU 502 Iontophoretic electrode 1988 IOMED Inc. Salt Lake City, UT, U.S.A. http://www.iomed.com (accessed 29 March 2005).
28. Laporte M. Eczéma de contact et ionisation médicamenteuse. Med Physica 1984; 7:97-9.
29. Monteiro-Riviere NA. Altered epidermal morphology secondary to lidocaine iontophoresis in vivo and in vitro studies in porcine skin. Fundam Appl Toxicol 1990; 15:174-85.